When was ThermoGenesis founded?

ThermoGenesis was founded in 1986 and raised its 1st funding round 23 years after it was founded.

Where is ThermoGenesis located?

ThermoGenesis is headquartered in Rancho Cordova, United States. It is registered at Rancho Cordova, California.

How many employees does ThermoGenesis have?

As of Dec 31, 2022, ThermoGenesis has 41 employees, reflecting a 3% year-over-year growth in headcount.

Is ThermoGenesis a funded company?

ThermoGenesis is a funded company, having raised an undisclosed amount across 5 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on May 21, 2009.

When was the latest funding round of ThermoGenesis?

ThermoGenesis' latest funding was a $***** Post IPO round on Mar 22, 2023, with participation from 0 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $413M in funding in 2026 to date.

What is the annual revenue of ThermoGenesis?

Annual revenue of ThermoGenesis is $18M as on Jun 30, 2013.

Where does ThermoGenesis rank among its competitors?

ThermoGenesis ranks 5th amongst 21 active competitors, of which 9 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Cellular Origins, which secured $40M in Dec, 2025.

Who are the top competitors of ThermoGenesis?

ThermoGenesis' top competitors include Ori Biotech, Multiply Labs and Cellular Origins. Among them, Cellular Origins secured the most recent funding round in December, 2025.

ThermoGenesis - 2026 Company Profile, Funding, Competitors & Financials

ThermoGenesis is a public company based in Rancho Cordova (United States), founded in 1986. It operates as a Provider of automated technologies for cell-based therapeutics and bio-processing. ThermoGenesis has raised an undisclosed amount in funding. The company has 21 active competitors, including 9 funded and 3 that have exited. Its top competitors include companies like Ori Biotech, Multiply Labs and Cellular Origins.

Company Details

ThermoGenesis is developing automated technologies for cell-based therapeutics and bio-processing. It offers automated clinical biobanking, point-of-care applications for cell-based therapeutics, and automation for immuno-oncology. It offers AXP BioArchive which provides automated isolation, collection and storage of cord blood stem cells. Another product, MXP allows automated processing of autologous peripheral or bone marrow-derived stem cells. CXP + BioArchive is the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology. The company operates as a wholly owned subsidiary of Cesca Therapeutics.

Website: thermogenesis.com
Social
Email ID: *****@thermogenesis.com
Phone Number: +1 **********
Part Of
Registered Address: Rancho Cordova, California

Key Metrics

Founded Year

1986

Location

Rancho Cordova, United States

Stage

Public

Latest Funding Round

Post IPO, Mar 22, 2023, $*****

Investors

Bay City Capital & 1 more

Ranked

5^th among 21 active competitors

Annual Revenue

$18M as on Jun 30, 2013

Employee Count

41 as on Dec 31, 2022

Similar Companies

Ori Biotech & 19 more

Exit Details

Public

View ThermoGenesis' full profile

ThermoGenesis is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Thermogenesis Corp. CIN: 943018487 , United States, Active	Dec 31, 1999	-	43 (As on Dec 31, 2019)	-
CESCA THERAPEUTICS INC. CIN: 811212 , United States, Active	Dec 25, 2018	$9.44M (As on Dec 31, 2023)	41 (As on Dec 31, 2022)	-
Thermogenesis Corp CIN: 811212 , United States, Active		$18M (As on Jun 30, 2013)	-	-

ThermoGenesis got listed on Aug 12, 2010.

Click here to take a look at ThermoGenesis's IPO in detail

ThermoGenesis has raised funding over 5 rounds. Its first funding round was on May 21, 2009. ThermoGenesis has 2 institutional investors.

Here is the list of recent funding rounds of ThermoGenesis:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 22, 2023	9451718	Post IPO	4427192	6000528	6828529	4265343
Sep 08, 2021	4002262	Grant (prize money)	4869032	2402281	2213052	HHS
Mar 26, 2018	4473206	Post IPO	1984230	6656000	7678039	2963639

Access funding benchmarks and valuations. Sign up today!

View details of ThermoGenesis's funding rounds and investors

ThermoGenesis' employee count trend

ThermoGenesis has 41 employees as of Dec 22. The total employee count is 2.0% more than what it was in Dec 21. Here is ThermoGenesis's employee count trend over the years:

Uncover ThermoGenesis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ThermoGenesis include Ori Biotech, Multiply Labs and Cellular Origins. Here is the list of Top 10 competitors of ThermoGenesis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ori Biotech 2015, London (United Kingdom), Series B	Provider of manufacturing technology for cell and gene therapies	$281M	Novalis LifeSciences, Octopus Ventures & 20 others	66/100
2nd	Multiply Labs 2016, San Francisco (United States), Series A	Manufacturer of precision medicines through innovative robotic technology	$41.3M	Zillionize, Casdin Capital & 22 others	63/100
3rd	Cellular Origins 2021, Cambridge (United Kingdom), Series A	Provider of automated manufacturing solution for cell and gene therapy	$40M	Johnson & Johnson, The Technology Partnership ... & 3 others	52/100
4th	Celltrio 2018, Santa Clara (United States), Series B	Developer of automated biobanking and cell culture systems	$15M	Premier Partners	45/100
5th	ThermoGenesis 1986, Rancho Cordova (United States), Public	Provider of automated technologies for cell-based therapeutics and bio-processing	-	Bay City Capital, HHS	42/100
6th	Unicorn Biotechnologies 2020, Cambridge (United Kingdom), Seed	Developer of bioreactors for cell-based manufacturing	$3.2M	Acequia Capital, HAX & 9 others	41/100
7th	Curiosis 2015, South Korea, Public	Developer of automation technologies for life science research laboratories	-	Knet Investment Partners, Alpen Route	41/100
8th	Shenzhen Shenyan Biotechnology 2014, Shenzhen (China), Series B	Developer of automated cell processing system	$56.7M	Eight Roads Ventures, Tasly & 3 others	38/100
9th	Iorgan 2024, Chapel Hill (United States), Seed	Developer of a platform for AI-guided cell manufacturing and development	$2M	First Star Ventures, Terasaki & 4 others	30/100
10th	Guangdong Bogong Medical Technology 2022, Dongguan (China), Series A	Developer of robotic solution for life science research	-	Lime Capital, Endeavor Fund	30/100